Nobuhiro Kado
Shizuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
The Efficacy of Local Treatment for Recurrent Endometrial Cancer.
Journal: The journal of obstetrics and gynaecology research
Published: February 05, 2026
Exceptional Response to Lenvatinib plus Pembrolizumab after Pembrolizumab Failure in MLH1-Methylated Deficient Mismatch Repair/Microsatellite Instability-High Endometrial Cancer: A Case Report.
Journal: Case reports in oncology
Published: December 24, 2025
Uptake of cascade tests in relatives of patients undergoing cancer precision medicine in Japan.
Journal: Japanese journal of clinical oncology
Published: November 20, 2025
Pulmonary Collision Tumor Comprising Lung Adenocarcinoma and Metastatic Endometrial Cancer: A Case Report.
Journal: Thoracic cancer
Published: September 04, 2025
Factors affecting the implementation of cascade testing of patients with BRCA1 or BRCA2 pathogenic germline variants in Japan.
Journal: Journal of genetic counseling
Published: December 03, 2024
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.
Journal: Journal of gynecologic oncology
Published: November 27, 2024
A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy.
Journal: Investigational new drugs
Published: August 14, 2024
Two Japanese families with familial pancreatic cancer with suspected pathogenic variants of CDKN2A: a case report.
Journal: Hereditary cancer in clinical practice
Published: April 30, 2024
Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002).
Journal: Journal of Cancer
Published: October 30, 2023
A Japanese Family Meeting the Clinical Diagnostic Criteria for MEN1 with a MEN1 Variant of Uncertain Significance.
Journal: Internal medicine (Tokyo, Japan)
Published: September 04, 2023
A Japanese case of ovarian mucinous adenocarcinoma with germline double variants of MSH2 and BRCA2.
Journal: Journal of human genetics
Published: April 17, 2023
A Japanese case of familial malignant melanoma with germline CDK4 variant incidentally diagnosed by cancer genome profiling.
Journal: Journal of human genetics
Published: October 07, 2022
Last Updated: 09/26/2026